Impact of pharmacodynamic biomarkers in immuno-oncology phase 1 clinical trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Impact of pharmacodynamic biomarkers in immuno-oncology phase 1 clinical trials

Published:2022-09 Issue: Volume:173 Page:167-177
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Salawu Abdulazeez^ORCID,Hernando-Calvo Alberto^ORCID,Chen Rachel Y.^ORCID,Araujo Daniel V.^ORCID,Oliva Marc^ORCID,Liu Zhihui A.,Siu Lillian L.^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference31 articles.

1. Comprehensive analysis of the clinical immuno-oncology landscape;Tang;Ann Oncol,2018

2. Combinations take centre stage in PD1/PDL1 inhibitor clinical trials;Upadhaya;Nat Rev Drug Discov,2021

3. The wild west of checkpoint inhibitor development;Beaver;N Engl J Med,2022

4. Analysis of impact of post-treatment biopsies in phase I clinical trials;Sweis;J Clin Oncol,2016

5. Early-drug development in the era of immuno-oncology: are we ready to face the challenges?;Ochoa de Olza;Ann Oncol,2018

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An update on the status of HSP90 inhibitors in cancer clinical trials;Cell Stress and Chaperones;2024-08

2. Critical importance of correctly defining and reporting secondary endpoints when assessing the ethics of research biopsies;Clinical Trials;2024-04-23

3. Optimizing dose-schedule regimens with bayesian adaptive designs: opportunities and challenges;Frontiers in Pharmacology;2023-11-23

4. Currently Used Methods to Evaluate the Efficacy of Therapeutic Drugs and Kidney Safety;Biomolecules;2023-10-26

5. A pan-cancer clinical platform to predict immunotherapy outcomes and prioritize immuno-oncology combinations in early-phase trials;Med;2023-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3